Because Medicare covers the drug, patients with privately run Medicare Advantage plans will receive coverage, said Juliette Cubanski, of the non-profit KFF, which researches health care issues.
Insurers won't cover new Alzheimer's treatment Leqembi for some customers
→
Everyone values innovation and treatments for cures for diseases like hepatitis C,” said Juliette Cubanski, deputy director of the program on Medicare policy at the Kaiser Family Foundation, a nonpartisan health care policy organization.
Washington takes on Big Pharma: Lower drug prices vs. fewer new cures
→
